Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant

American Journal of Epidemiology

Volumn 170, Issue 10, 2009, Pages 1268-1278

  Steenland, Kyle ^a   Tinker, Sarah ^a   Frisbee, Stephanie ^b   Ducatman, Alan ^b   Vaccarino, Viola ^a,c  

^a EMORY UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cholesterol; Fluorocarbons; Lipids; Triglycerides; Water supply

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; TRIACYLGLYCEROL;

AGE CLASS; BIOCHEMICAL COMPOSITION; BIOCHEMISTRY; CHEMICAL POLLUTANT; DENSITY; HEALTH RISK; INDUSTRIAL WASTE; LIPID; MEDICAL GEOGRAPHY; SERUM; SURFACTANT; TEMPORAL RECORD; WATER SUPPLY;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CHEMICAL INDUSTRY; CHOLESTEROL BLOOD LEVEL; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FLUID INTAKE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; UNITED STATES; WATER CONTAMINATION;

AGED; AIR POLLUTANTS; ALKANESULFONIC ACIDS; CHEMICAL INDUSTRY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; FLUOROCARBONS; HUMANS; LINEAR MODELS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OCTANOIC ACIDS; OHIO; SOIL POLLUTANTS; STATISTICS AS TOPIC; TRIGLYCERIDES; WATER POLLUTANTS, CHEMICAL; WEST VIRGINIA;

NORTH AMERICA; UNITED STATES; WEST VIRGINIA;

EID: 70350700500     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp279     Document Type: Article

References (25)

1. Calafat AM, Wong LY, Kuklenyik Z, et al. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115(11):1596-1602.
2. Olsen GW, Burris JM, Ehresman DJ, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesul-fonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007;115(9): 1298-1305.
3. Kennedy GL Jr, Butenhoff JL, Olsen GW, et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol. 2004;34(4): 351-384.
4. Draft risk assessment of the potential human health effects associated with exposure to perfluorooctanoic acid and its salts. Washington, DC: Risk Assessment Division, Office of Pollution Prevention and Toxics, Environmental Protection Agency, 2005. (www.epa.gov/oppt/pfoa/pubs/pfoarisk.pdf).
5. Fei C, McLaughlin JK, Tarone RE, et al. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect. 2007;115(11):1677-1682.
6. Apelberg BJ, Witter FR, Herbstman JB, et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect. 2007;115(11):1670-1676.
7. Sakr CJ, Kreckmann KH, Green JW, et al. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. J Occup Environ Med. 2007;49(10):1086-1096.
8. Sakr CJ, Leonard RC, Kreckmann KH, et al. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J Occup Environ Med. 2007;49(8):872-879.
9. Olsen GW, Zobel LR. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health. 2007;81(7):231-246.
10. Emmett EA, Zhang H, Shofer FS, et al. Community exposure to perfluorooctanoate: relationships between serum levels and certain health parameters. J Occup Environ Med. 2006;48(8): 771-779. (Pubitemid 44221831)
11. Olsen GW, Burris JM, Burlew MM, et al. Plasma cholecys-tokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem Toxicol. 2000;23(4):603-620.
12. Costa G, Sartori S, Consonni D. Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med. 2009;51(3):364-372.
13. Olsen GW, Burris JM, Mandel JH, et al. Serum perfluorooc-tane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. J Occup Environ Med. 1999;41(9):799-806.
14. Steenland K, Jin C, MacNeil J, et al. Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect. 2009;117(7):1083-1088.
15. Flaherty JM, Connolly PD, Decker ER, et al. Quantitative determination of perfluorooctanoic acid in serum and plasma by liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;819(2): 329-338.
16. Longnecker MP, Smith CS, Kissling GE, et al. An interla-boratory study of perfluorinated alkyl compound levels in human plasma. Environ Res. 2008;107(2):152-159.
17. Frost PH, Havel RJ. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol. 1998;81(4A): 26B-31B.
18. Loveless SE, Finlay C, Everds NE, et al. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology. 2006;220(2-3):203-217.
19. DeWitt JC, Shnyra A, Badr MZ, et al. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol. 2009;39(1):76-94.
20. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837-1847.
21. Kastelein JJ, van der Steeg WA, Holme I, et al. Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment. Circulation. 2008;117(23):3002-3009.
22. Fernandez ML, Webb D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J Am Coll Nutr. 2008;27(1):1-5.
23. Kannan K, Corsolini S, Falandysz J, et al. Perfluorooctane-sulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol. 2004;38(17):4489-4495.
24. Leonard RC, Kreckmann KH, Sakr CJ, et al. Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. Ann Epidemiol. 2008;18(1):15-22.
25. Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. J Occup Med. 1993; 35(9):950-954.